The use of cannabidiol (CBD) in pain reduction for knee osteoarthritis. A Double-Blind Randomized Control Study

Go Back to All Clinical Trials

The use of cannabidiol (CBD) in pain reduction for knee osteoarthritis. A Double-Blind Randomized Control Study

Brief description of study

This will be a multi-center, double-blinded randomized controlled study. The study is comparing pain, patient satisfaction, in two cohorts: patients with knee OA undergoing physiotherapy who receive CBD and a placebo group. Patients will be asked on treatment Day 1, 2, 7, and 14, 28, and 42 to rate their pain according to the VAS scale. Additionally, patient satisfaction will be measured.

Clinical Study Identifier: s21-00334

ClinicalTrials.gov Identifier: NCT05020028

Principal Investigator: Michael J Alaia.

Other Investigators: Laith M Jazrawi, Ran R Schwarzkopf, Abigail L Campbell, Lauren E. Borowski, Jonathan Samuels.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies